282 related articles for article (PubMed ID: 5720870)
1. Role of catecholamines in the central effects of amphetamine.
Pfeifer AK; György L; Fodor M
Acta Med Acad Sci Hung; 1968; 25(3):441-50. PubMed ID: 5720870
[No Abstract] [Full Text] [Related]
2. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
Pfeifer AK; Galambos E
Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
[No Abstract] [Full Text] [Related]
3. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
Dominic JA; Moore KE
Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
[No Abstract] [Full Text] [Related]
4. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
Rech RH; Carr LA; Moore KE
J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
[No Abstract] [Full Text] [Related]
5. Behavioral and catecholamine depleting effects of alpha-methyl-5-hydroxytryptophan.
Dominic JA; Moore KE
Eur J Pharmacol; 1969 Dec; 8(3):292-5. PubMed ID: 5308817
[No Abstract] [Full Text] [Related]
6. Study on the mechanism of the metabolism increase by amphetamine and by the elevation of brain catecholamines.
Pfeifer AK
Act Nerv Super (Praha); 1972 Nov; 14(4):295-7. PubMed ID: 5083834
[No Abstract] [Full Text] [Related]
7. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
Beuthin FC; Miya TS; Blake DE; Bousquet WF
J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
[No Abstract] [Full Text] [Related]
8. The effect of L-DOPA on brain catecholamines and motility in rats.
Maj J; Grabowska M; Mogilnicka E
Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
[No Abstract] [Full Text] [Related]
9. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
[No Abstract] [Full Text] [Related]
10. Stimulus-dependent antagonism of the alpha-methyltyrosine-induced lowering of brain catecholamines by (+)-amphetamine in intact mice.
Welch BL; Welch AS
J Pharm Pharmacol; 1967 Dec; 19(12):841-3. PubMed ID: 4384230
[No Abstract] [Full Text] [Related]
11. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
Buterbaugh GG; Spratt JL
J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
[No Abstract] [Full Text] [Related]
12. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
Proctor CD; Kirby J; Wood MH; Wade LH; King PK
Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
[No Abstract] [Full Text] [Related]
13. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
[TBL] [Abstract][Full Text] [Related]
14. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
[No Abstract] [Full Text] [Related]
15. Tyrosine hydroxylase inhibitors.
Moore KE; Dominic JA
Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
[No Abstract] [Full Text] [Related]
16. [Role of central catecholamines in the psychostimulant activity of pyrovalerone].
Fauquet JP; Morel E; Demarty C; Rapin JR
Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):325-37. PubMed ID: 1035081
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between seizure susceptibility and brain catecholamine levels. An experimental study using a kindling preparation].
Sato M; Nakashima T; Mitsunobu K; Otsuki S
No To Shinkei; 1976 May; 28(5):471-7. PubMed ID: 140696
[TBL] [Abstract][Full Text] [Related]
18. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
Bloom FE; Aghajanian GK
J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
[No Abstract] [Full Text] [Related]
19. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
Cooper BR; Breese GR; Grant LD; Howard JL
J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
[No Abstract] [Full Text] [Related]
20. Pharmacologic properties and mechanism of action of amfonelic acid.
Aceto MD; Botton I; Martin R; Levitt M; Bentley HC; Speight PT
Eur J Pharmacol; 1970; 10(3):344-54. PubMed ID: 4393073
[No Abstract] [Full Text] [Related]
[Next] [New Search]
